AUSTIN, Texas, July 1, 2020 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life ...

Luminex’s xMAP Technology will be deployed by the HPA project to perform flexible and high-throughput screening of biomarkers using the HPA antibodies on large numbers of samples. The same technology ...

Luminex Corporation LMNX recently entered an agreement with EDP Biotech Corporation, wherein EDP will have the rights to develop, market and sell its blood-based colorectal cancer diagnostic assay, ...

Luminex’s xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP® Technology uses color-coded microspheres as the substrate on which ...

In order to emit less contaminants into the environment, and at the same time produce healthier foods that are free of those contaminants, all production systems should be investigated, i.e. whether ...

"We are excited to have scientists from around the world share their latest research and to see the continued growth in new applications for multiplexing technology," said Paul C. Ladestein, General ...

Luminex Corporation LMNX recently delivered the first of its new xMAP INTELLIFLEX Systems to several of its Life Science Research Partners. This marks a significant milestone in the company’s strategy ...

Have you ever arrived in a new city and needed to find the shortest route from one meeting to the next? Or maybe you've wanted a quick way to measure the distance for a jog. DeLorme's XMap Handheld ...